Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

We have limited Russian content available. View Russian content.

S&P Global Market Intelligence

Billionaire-led healthcare venture shines light on opaque supply chain, M&A need

Billionaire-led healthcare venture shines light on opaque supply chain, M&A need

  • 02.02.2018
  • min read

S&P Global Market Intelligence

Billionaire-led healthcare venture shines light on opaque supply chain, M&A need

Whether pharmacy benefit managers fundamentally change in the wake of the Amazon partnership with Berkshire Hathaway and JPMorgan, their link in the chain likely will not, according to Tim van Biesen, a partner with Bain & Company and a leader of their healthcare practice. "You have to manage drug benefits, because if you don't, you return all the pricing leverage back to the pharmaceutical companies," he said.